Why is the Brainchip share price tumbling 7% on Thursday?

This semiconductor company's shares are under pressure again. But why?

The Brainchip Holdings Ltd (ASX: BRN) share price has returned from its trading halt on Thursday.

In morning trade, the semiconductor company's shares are down 7.5% to 18.5 cents.

A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.

Image source: Getty Images

Why is the Brainchip share price sinking?

Investors have been selling down the company's shares this morning for a couple of reasons.

One is the announcement of a capital raising and the other is the release of its quarterly update.

In respect to the former, Brainchip has announced a $25 million equity capital raising. This comprises a fully underwritten institutional placement to raise approximately $20 million, a fully underwritten sale of existing securities from LDA Capital, and a non-underwritten share purchase plan (SPP).

These funds will be raised at 19.3 cents per new share, which is a surprisingly modest 3.5% discount to where the Brainchip share price last traded.

According to the release, proceeds from the equity capital raising will be used to support the commercialisation of the company's Akida 2.0 technology and the development, commercialisation and productisation of its new TENNs product.

It believes the latter represents the next evolution in its product portfolio and builds on its existing position in neuromorphic technology.

Commenting on the equity raising, the company's under fire CEO, Sean Hehir, said:

I am very pleased with the outcome from this capital raise, which will allow BrainChip to continue its efforts to bring Akida 2.0 to market as well as develop new products based on our TENNs algorithm that will compliment and accentuate the strengths in our core Akida technology. We are also very pleased to have received the support of a number of quality Australian institutional investors, and to be able to offer our retail investors the opportunity to invest on the same terms through the SPP. At our AGM in May, shareholders made it clear they wanted us to consider adding an SPP into any future capital raise. We heard that message loud and clear, and we have added an SPP into this placement precisely for that reason.

Quarterly update

It was another bitterly disappointing quarter for the company in respect to cash receipts.

Brainchip reported less cash receipts than a Boost Juice stand for the three months, pulling in just US$48,000. This was despite spending over US$3.9 million on operating activities during the period.

Management blamed its long sales cycle times and once again "remains optimistic based on the number of active engagements and level of interest from our prospective customers."

The Brainchip share price is down 48% since this time last year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »

Business man marking buy on board and underlining it.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Brokers believe that now could be the time to buy these shares.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Broker Notes

2 ASX shares tipped to grow up to 122% in the next 12 months

These companies could be on the cusp of something big.

Read more »

Man typing on his laptop with a coffee mug at the side.
ASX Share Market News

5 things to watch on the ASX 200 on Friday

On Thursday, the S&P/ASX 200 Index (ASX: XJO) was out of form again and dropped into the red. The benchmark index fell…

Read more »

Thumbs down Facebook icon over dark screen.
Broker Notes

Why these 5 ASX shares were downgraded by brokers this week

Market analysts explain why they've downgraded these ASX stocks.

Read more »